Dariusz Kotlęga Selected Research

9-hydroxyoctadecadienoic acid

10/2021

Prostaglandin E2, 9S-, 13S-HODE and resolvin D1 are strongly associated with the post-stroke cognitive impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dariusz Kotlęga Research Topics

Disease

14	Stroke (Strokes) 05/2022 - 01/2014
13	Ischemic Stroke 05/2022 - 03/2012
5	Atherosclerosis 04/2021 - 03/2012
3	Atrial Fibrillation 03/2019 - 03/2012
2	Cognitive Dysfunction 10/2021 - 01/2021
2	Inflammation (Inflammations) 04/2021 - 01/2020
1	Vascular Diseases (Vascular Disease) 10/2021
1	Neuroinflammatory Diseases 10/2021
1	Brain Edema (Cerebral Edema) 04/2021
1	Dementia (Dementias) 01/2021
1	Myocardial Infarction 10/2020
1	Embolic Stroke 03/2019
1	Coronary Disease (Coronary Heart Disease) 05/2016
1	Fatigue 01/2016
1	Hemorrhagic Stroke 01/2015
1	Cerebral Hemorrhage 01/2015
1	Atherosclerotic Plaque (Atheroma) 01/2015
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2015
1	Hypertension (High Blood Pressure) 01/2014
1	Dyslipidemias (Dyslipidemia) 01/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2014

Drug/Important Bio-Agent (IBA)

4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2019 - 03/2012
3	Arachidonic Acid (Vitamin F)IBA 05/2022 - 01/2020
2	ThromboxanesIBA 05/2022 - 10/2021
2	EicosanoidsIBA 10/2021 - 01/2020
2	Nonesterified Fatty Acids (NEFA)IBA 10/2021 - 01/2021
2	LipoxinsIBA 04/2021 - 01/2020
2	Eicosapentaenoic AcidIBA 01/2021 - 10/2020
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020 - 01/2018
2	LipidsIBA 05/2016 - 01/2014
2	C-Reactive ProteinIBA 04/2014 - 01/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2021
1	Thromboxane B2IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	9-hydroxyoctadecadienoic acidIBA 10/2021
1	N 30IBA 10/2021
1	resolvin D1IBA 10/2021
1	Dinoprostone (PGE2)FDA Link 10/2021
1	lipoxin A4IBA 04/2021
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 04/2021
1	methyl ester 5(S),6(R)-7-trihydroxyheptanoic acidIBA 04/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021
1	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2021
1	tricosanoic acidIBA 01/2021
1	stearidonic acidIBA 01/2021
1	CytokinesIBA 10/2020
1	Docosahexaenoic AcidsIBA 10/2020
1	resolvin D2IBA 10/2020
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 05/2017
1	Valine (L-Valine)FDA Link 05/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2017
1	Methionine (L-Methionine)FDA Link 05/2017
1	Levodopa (L Dopa)FDA LinkGeneric 01/2016
1	HDL CholesterolIBA 01/2015
1	Anti-Idiotypic AntibodiesIBA 01/2014
1	oxidized low density lipoproteinIBA 01/2014
1	AntibodiesIBA 01/2014
1	Oxidoreductases (Dehydrogenase)IBA 03/2012

Therapy/Procedure

4	Therapeutics 10/2021 - 01/2014
2	Secondary Prevention 05/2016 - 03/2012
1	Transcranial Magnetic Stimulation 05/2017
1	Stroke Rehabilitation 05/2017